Welcome to Labeled Immunoassays and Clinical Medicine website!
Orignal Article

Analysis of Deletion Mutation in Dystophin Gene of Duchene/Becker Muscular Dystrophy Suspected Pediatric Patients

  • GUO Ya-jie ,
  • WANG Yong-hong ,
  • TONG Yue-juan ,
  • SHEN Chen
Expand
  • Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics, Ministry of Education,Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, Beijing 100045, China

Received date: 2013-03-12

  Online published: 2013-08-20

Abstract

Objective To investigate the distribution feature of dystrophin gene deletion mutations in Chinese Han Duchenne/Becker muscular dystrophy (DMD/BMD)pediatric patients. Methods Determination of deletion mutation in dystophin gene of 964 DMD/BMD suspected pediatric patients was performed by amplifying 20 segments of major deletion “hot spot” region with polymerase chain reaction (PCR).The deletion pattern of dystophin gene was consequently summarized and the distribution of breakpoints of dystophin gene deletion mutation was also analyzed.Results The total 491cases (51.0%) had confirmed deletion mutations. Mutations in 75 cases (15.2%) located in the region of 5’-flanking region, 402 cases (81.7%) in the region of central region,and 13 cases (2.6%) deletions span in both 5’-flanking and central regions.The most common deletions including exon 50, 49 and 48 deletions ranked the top. 74%of deletion breakpoints fell in introns 44~50 in dystophin gene, in which about 21% of deletion breakpoints fell in intron 44. Conclusion The study indicates that more than half of suspected DMD/BMD cases are confirmed deletion mutation in dystophin gene. Deletion mutations are mostly distributed in the central region of DMD gene in Chinese Han pediatric population.

Cite this article

GUO Ya-jie , WANG Yong-hong , TONG Yue-juan , SHEN Chen . Analysis of Deletion Mutation in Dystophin Gene of Duchene/Becker Muscular Dystrophy Suspected Pediatric Patients[J]. Labeled Immunoassays and Clinical Medicine, 2013 , 20(3) : 172 -175 . DOI: 10.11748/bjmy.issn.1006-1703.2013.03.016

References

[1] Emery A E. The muscular dystrophies [J]. Lancet,2002,359(9307):687-695.
[2] Aartsma-Rus A, Van Deutekom J C, Fokkema I F, et al. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule[J]. Muscle Nerve,2006,34(2):135-144.
[3] 周永安, 席卫平, 夏丽, 等.多重聚合酶链反应检测DMD/BMD患者的基因缺失[J].中国优生与遗传杂志,2009,17(9):18-19.
[4] Chamberlain J S, Gibbs R A, Ranier J E, et al. Deletion screening of Duchenne muscular dystrophy locus via multiplex DNA amplification[J].Nucleic Acid Res,1988,16:11141-11156.
[5] Beggs A H, Koenig M, Boyce F M, et al. Detect ion of 98% of DMD /BMD gene deletion by polym erase chain reaction [J].Hum Genet,1990,86: 45.
[6] Pozzoli U, Sironi M, Cagliani R, et al. Comparative analysis of the human dystrophin and utrophin gene structures[J].Genetics,2002,160:793-798.
[7] 盛文利, 陈江瑛, 朱良付, 等.应用多重聚合酶连反应与聚丙烯酰胺凝胶电泳提高肌营养不良基因缺失检出率[J].中华检验医学杂志,2002,25(2):82-84.
[8] 闫杨, 杨晓凤,尹富华,等.135例Duchenne型肌营养不良症DMD基因缺失分析[J]. 基础医学与临床, 2009,29:872-874.
[9] 郑世珍,胡华,李瑾,等.多重PCR检测DMD/BMD患者DMD基因外显子缺失的研究[J]. 解放军医学杂志, 2010, 35(10):1208-1211.
[10] 牛国辉, 麻宏伟, 姜俊, 等.多重PCR技术及定量PCR技术在缺失型Duchenne型肌营养不良患儿及携带者诊断中的应用研究[J].中国实用儿科杂志,2005,20(4):224-226.
[11] Todoroya A, Boronzova J, Miorin M, et al. Mutation analysis in Duchenne and Becker muscular dystronphy patients from Bulgaria shows a peculiar distribution of breakpoints by intron[J]. Am J Med Genet,1996,65:40-43.
[12] Florentin L, Mavrou A, Kekou K, et al. Deletion patterns of Duchenne and Becker muscular dystrophies in Greece[J]. J Med Genet,1995,32:48-51.
[13] Gokgoz N, Kuseyri F, Topaloglu H, et al. Screening of deletions and PFLP analysis in Turkish DMD/BMD families by PCR[J].Clin Genet,1993,43:261-266.
[14] Yokota T, Duddy W, Echigoya Y, et al. Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?[J] Expert Opin Biol Ther, 2012,12(9):1141-1152.
[15] Arechavala-Gomeza V, Anthony K, Morgan J, et al. Antisense oligonucleotide-mediated exon skipping for duchenne muscular dystrophy: progress and challenges[J].Curr Gene Ther, 2012,12(3):152-160.
[16] Benchaouir R, Goyenvalle A. Splicing modulation mediated by small nuclear RNAs as therapeutic approaches for muscular dystrophies[J].Curr Gene Ther, 2012,12(3):179-191.
Outlines

/